NBP255870PE

Novus Biologicals™ Cdk5 Recombinant Protein Antigen

Manufacturer: Novus Biologicals™

Select a Size

Pack Size SKU Availability Price
Each of 1 NBP255870PE-Each-of-1 In Stock ₹ 31,372.50

NBP255870PE - Each of 1

₹ 31,372.50

In Stock

Quantity

1

Base Price: ₹ 31,372.50

GST (18%): ₹ 5,647.05

Total Price: ₹ 37,019.55

Gene ID (Entrez)

1020

Common Name

Cdk5 Recombinant Protein Antigen

Formulation

PBS and 1M Urea, pH 7.4.

Gene Alias

Cell division protein kinase 5, cyclin-dependent kinase 5, EC 2.7.11, EC 2.7.11.22, protein kinase CDK5 splicing, PSSALRE, Serine/threonine-protein kinase PSSALRE, Tau protein kinase II catalytic subunit, TPKII catalytic subunit

Label Type

Unlabeled

Quantity

100μL

Source

E.Coli

Purification Method

>80% by SDS-PAGE and Coomassie blue staining

Content And Storage

Store at −20C. Avoid freeze-thaw cycles.

For Use With (Application)

Blocking/Neutralizing, Control

Gene Symbol

CDK5

Product Type

Recombinant Protein Antigen

Regulatory Status

RUO

Specific Reactivity

This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-52780. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml

Related Products

Img

Novus Biologicals™

NBP255913PE

--

Img

Novus Biologicals™

NBP255134PE

--

Img

Novus Biologicals™

NBP256081PE

--

Img

Novus Biologicals™

NBP255777PE

--

Img

Novus Biologicals™

NBP256302PE

--

Img

Novus Biologicals™

NBP255192PE

--

Img

Novus Biologicals™

NBP255514PE

--

Img

Novus Biologicals™

NBP255717PE

--

Description

  • A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human Cdk5
  • Source: E.coli Amino Acid Sequence: TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP The Cdk5 Recombinant Protein Antigen is derived from E
  • coli
  • The Cdk5 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.